Ind-Ra

INDIA RATINGS – Pharmaceutical Formulators Diverge on Strategy for Non-Prescription Businesses

Mumbai, April 21, 2018: India Ratings and Research (Ind-Ra) expects Indian formulators to continue to make investments to grow their domestic…

7 years ago

Acquisition of European Generic Businesses Partially Comforting to Indian Formulators

Acquisitions Carry Risks and May Outweigh Benefits Targeted to Counter Near to Medium term Profitability Concerns New Delhi, March 13,…

7 years ago